| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/22/2001 | WO2001012661A2 RECEPTOR-MEDIATED UPTAKE OF AN EXTRACELLULAR BCL-xL FUSION PROTEIN INHIBITS APOPTOSIS |
| 02/22/2001 | WO2001012660A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 02/22/2001 | WO2001012659A2 Human dna sequences |
| 02/22/2001 | WO2001012658A2 Human icos ligand and application thereof |
| 02/22/2001 | WO2001012657A2 Methods and means for selenoprotein expression |
| 02/22/2001 | WO2001012656A1 Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1 |
| 02/22/2001 | WO2001012655A1 Peptides consisting of fragments of gli-1 and sufuh and their use |
| 02/22/2001 | WO2001012654A2 Orally active peptides that prevent cell damage and death |
| 02/22/2001 | WO2001012651A2 Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neural cell differentiation |
| 02/22/2001 | WO2001012649A1 Aga |
| 02/22/2001 | WO2001012648A1 Novel transcription factor, bp1 |
| 02/22/2001 | WO2001012647A1 Gene expression modulated in ataxia telangiectasia tumorgenesis |
| 02/22/2001 | WO2001012645A1 HUMAN sbhPARS2 |
| 02/22/2001 | WO2001012598A2 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 02/22/2001 | WO2001012244A1 Use of fibrinogen multimers |
| 02/22/2001 | WO2001012238A1 An animal model of polyglutamine toxicity, methods of use, and modulators of polyglutamine toxicity |
| 02/22/2001 | WO2001012234A1 Gene transfer imaging and uses thereof |
| 02/22/2001 | WO2001012232A2 Process to make a sustained release formulation |
| 02/22/2001 | WO2001012220A1 Non-immunosuppressant hiv tat |
| 02/22/2001 | WO2001012219A1 Pneumococcal vaccines |
| 02/22/2001 | WO2001012216A1 Heat shock fusion-based vaccine system |
| 02/22/2001 | WO2001012215A2 Protective antigen of epstein barr virus |
| 02/22/2001 | WO2001012213A2 Ttp-related zinc finger domains and methods of use |
| 02/22/2001 | WO2001012127A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 02/22/2001 | WO2001012126A2 Cardiomyocyte regeneration |
| 02/22/2001 | WO2001011970A1 yloV |
| 02/22/2001 | WO2001011960A1 A mucosal specific gene delivery system based on modified bacterial exotoxin |
| 02/22/2001 | WO2001011950A1 Transgenic animals that produce altered wool |
| 02/22/2001 | WO2001011949A1 Cd39/ecto-adpase for treatment of thrombotic and ischemic disorders |
| 02/22/2001 | WO2001011946A1 Construction of barley with decreased gel protein content |
| 02/22/2001 | WO2001011937A2 Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines |
| 02/22/2001 | WO2000078941A3 Methods and products for manipulating uncoupling protein expression |
| 02/22/2001 | WO2000078788B1 NOVEL cDNA ASSOCIATED WITH RENAL DISEASE |
| 02/22/2001 | WO2000073330A3 Method and compositions relating to insulin resistance disorders |
| 02/22/2001 | WO2000072863A3 Uses of h-trek-1 polypeptides and polynucleotides encoding them |
| 02/22/2001 | WO2000072742A3 Methods and materials for generating sh3 domains with tailored binding properties |
| 02/22/2001 | WO2000072008A3 Identification of novel mechanisms of drug resistance |
| 02/22/2001 | WO2000071737A3 Improved retroviral production by inhibition of the enveloppe cell receptor |
| 02/22/2001 | WO2000064936A3 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2 |
| 02/22/2001 | WO2000061761A3 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
| 02/22/2001 | WO2000055633A3 Methods of screening for colorectal cancer modulators |
| 02/22/2001 | WO2000043521A3 Endogenetic nucleic fragment associated with an autoimmune disease, marking method and reagent |
| 02/22/2001 | WO2000040614A3 Characterization of the soc/crac calcium channel protein family |
| 02/22/2001 | WO2000039297A3 Il-1 related polypeptides |
| 02/22/2001 | WO2000036107A3 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 02/22/2001 | WO2000025728A3 Chromosome 2 sequence of the human malaria parasite plasmodium falciparum and proteins of said chromosome useful in anti-malarial vaccines and diagnostic reagents |
| 02/22/2001 | WO2000022131A3 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 02/22/2001 | WO1999049883A3 Oxidized thymosin beta 4 |
| 02/22/2001 | WO1999047553A3 Bacterial yeal family members as targets for antimicrobial drug design |
| 02/22/2001 | DE19939578A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination |
| 02/22/2001 | DE19939246A1 Refolding membrane proteins into their native or active form comprises solubilizing the protein in a first detergent and replacing the first detergent with a second detergent |
| 02/22/2001 | DE19937837A1 New human gene OLFXX, encoding an olfactory receptor, useful for diagnosis, treatment and development of pharmaceuticals |
| 02/22/2001 | DE19937719A1 New nucleic acid from phage phiCh1, used to create vectors for expressing proteins and polymers in halophilic Archaea |
| 02/22/2001 | CA2464845A1 Hematopoietic regulatory factors and methods of use thereof |
| 02/22/2001 | CA2385487A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | CA2385475A1 18 human secreted proteins |
| 02/22/2001 | CA2385431A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2383922A1 Cytokine receptor common gamma chain like |
| 02/22/2001 | CA2383691A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | CA2383264A1 Binary encoded sequence tags |
| 02/22/2001 | CA2383154A1 Baff receptor (bcma), an immunoregulatory agent |
| 02/22/2001 | CA2382251A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 02/22/2001 | CA2382148A1 25 human secreted proteins |
| 02/22/2001 | CA2382095A1 Methods of inhibiting binding of .beta.-sheet fibril to rage and consequences thereof |
| 02/22/2001 | CA2382056A1 Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1 |
| 02/22/2001 | CA2382048A1 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 02/22/2001 | CA2382018A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2382015A1 Membrane associated proteins |
| 02/22/2001 | CA2381985A1 Vegf-d and angiogenic use thereof |
| 02/22/2001 | CA2381981A1 Orally active peptides that prevent cell damage and death |
| 02/22/2001 | CA2381979A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | CA2381978A1 Ppar.delta. links apc to chemopreventive drugs |
| 02/22/2001 | CA2381941A1 System for monitoring the expression and/or location of transgenes |
| 02/22/2001 | CA2381863A1 Novel transcription factor, bp1 |
| 02/22/2001 | CA2381798A1 Method for treatment of .beta.-hemoglobinopathies |
| 02/22/2001 | CA2381794A1 Helical cytokine zalpha48 |
| 02/22/2001 | CA2381712A1 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 02/22/2001 | CA2381706A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | CA2381330A1 Male sterile plants |
| 02/22/2001 | CA2380991A1 Protective antigen of epstein barr virus |
| 02/22/2001 | CA2380983A1 Methods for identification of compounds stimulating insulin secretion |
| 02/22/2001 | CA2380635A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor |
| 02/22/2001 | CA2379940A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 02/22/2001 | CA2379647A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
| 02/22/2001 | CA2379259A1 Construction of barley with decreased gel protein content |
| 02/22/2001 | CA2379196A1 Rotavirus vaccine formulations |
| 02/21/2001 | EP1077264A2 DNA chip, PNA chip, and their preparation methods |
| 02/21/2001 | EP1077260A1 Parvovirus NS1 variants |
| 02/21/2001 | EP1077259A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF |
| 02/21/2001 | EP1077258A1 Human hrpi |
| 02/21/2001 | EP1077257A1 Photoinhibitory promoter |
| 02/21/2001 | EP1077219A1 Transcriptional regulatory factor |
| 02/21/2001 | EP1076720A2 NUCLEOTIDE SEQUENCES FOR DETECTING ENTEROHEMORRHAGIC $i(ESCHERICHIA COLI) (EHEC) |
| 02/21/2001 | EP1076717A1 Recombinant baculovirus-based insecticides |
| 02/21/2001 | EP1076713A1 Human bmp-7 promoter and method for exploring bone-related substance by using the same |
| 02/21/2001 | EP1076711A2 Human apoptosis associated proteins |
| 02/21/2001 | EP1076710A2 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 02/21/2001 | EP1076708A2 Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b 12 transport |
| 02/21/2001 | EP1076707A1 PLASMID FOR GENE EXPRESSION IN $i(PICHIA CIFERRII) AND TRANSFORMATION METHOD USING THE SAME |
| 02/21/2001 | EP1076706A2 Methods and compositions for expression of transgenes in plants |